AI assistant
Sending…
Sight Sciences, Inc. — Director's Dealing 2021
Jul 15, 2021
33763_dirs_2021-07-14_0dc5e889-c3d9-4ff4-9eea-e54eb935320d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2021-07-14
Reporting Person: O'Neil Shawn (Chief Commercial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.35 | 2027-11-28 | Common Stock (70000) | Direct | |
| Stock Option (Right to Buy) | $0.62 | 2029-04-16 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $1.96 | 2030-07-28 | Common Stock (50000) | Direct | |
| Stock Option (Right to Buy) | $10.96 | 2031-05-24 | Common Stock (70000) | Direct |
Footnotes
F1: The option vests and becomes exercisable as to 25% of the underlying securities on September 18, 2018 and in 36 equal monthly installments thereafter.
F2: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on April 18, 2019.
F3: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on August 30, 2020.
F4: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on June 24, 2021.
More from Sight Sciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Regulatory Filings
2026
May 29
Report Publication Announcement
2026
May 6
Legal Proceedings Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 22
Legal Proceedings Report
2026
Mar 30
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 5